---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-331409"
form_type: "8-K"
ticker: "INAB"
cik: "0001740279"
company_name: "IN8BIO, INC."
filed_at: "2021-11-17T23:59:59+00:00"
generated_at: "2026-06-28T07:26:10.880623+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# IN8bio appoints Dr. Trishna Goswami as Chief Medical Officer

## Summary
- Annual base salary of $450,000; eligible for annual bonus targeted at 40% of base; signing bonus $10,000.
- Awarded option to purchase 250,000 shares vesting over 4 years (25% at year 1).
- Severance includes 12 months base salary, prorated target bonus, and 9 months COBRA if terminated without cause or for good reason.
- Dr. Goswami previously led Trodelvy approvals at Gilead/Immunomedics; also worked at Stemline and AstraZeneca/MedImmune.
- Appointment effective November 15, 2021.

## SEC filing metadata
- accession: 0001193125-21-331409
- form_type: 8-K
- ticker: INAB
- cik: 0001740279
- company_name: IN8BIO, INC.
- filed_at: 2021-11-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1740279/000119312521331409/0001193125-21-331409-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1740279/000119312521331409/d238625d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-331409
- JSON: https://secwatch.observer/filing/0001193125-21-331409.json
- Plain text: https://secwatch.observer/filing/0001193125-21-331409.txt

## Key facts
- Executive change
  Trishna Goswami was appointed as Chief Medical Officer at IN8BIO, INC..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: Effective as of November 15, 2021, IN8bio, Inc. (the “ Company ”) appointed Dr. Trishna Goswami as the Company’s Chief Medical Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1740279/000119312521331409/0001193125-21-331409-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.